Report Highlights
The global market for blood cancer therapeutics was valued at $77.1 billion in 2025 and is projected to reach $125.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 10.2% from 2025 to 2030.
Report Includes
- 88 data tables and 63 additional tables
- An overview and analysis of the global blood cancer therapeutics market
- Analyses of global market trends, with revenue data for 2024, estimates for 2025, and projections of CAGRs through 2030
- Estimates of the current market size and growth prospects, with a market share analysis by cancer type, therapeutic class, and region
- Facts and figures related to market dynamics, including key drivers, restraints, challenges, and opportunities
- Review of macroeconomic factors and insights derived from Porter’s Five Forces analysis
- Overview of the regulatory landscape across North America, Europe, and Asia-Pacific
- Discussion of emerging technologies and developments, including clinical trials, pipeline analysis, and patent activity
- Detailed market analysis by blood cancer type, including leukemia, lymphoma, and multiple myeloma
- Regional market analysis covering North America, Europe, Asia-Pacific, the Middle East and Africa, and South America, with country-level data
- Analysis of the competitive landscape, including company share analysis and strategic initiatives
- Company profiles of major players within the industry, including Johnson & Johnson, Bristol-Myers Squibb Co., AbbVie Inc., Novartis AG, and F. Hoffmann-La Roche Ltd.
Report Scope
This report analyzes market trends for blood cancer therapeutics, providing data from 2024, 2025 estimates, compound annual growth rate projections through 2030 (forecast period: 2025–2030), and regional markets. It covers the market potential, competitive environment, regulatory scenarios, drivers, restraints, and opportunities, as well as market projections for 2030 and market share for key companies.
The market scope in this report is segmented by type into leukemia, lymphoma, multiple myeloma, and rare blood disorders. Leukemia is further subdivided into acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myelogenous (myeloid) leukemia (AML), and chronic myelogenous (myeloid) leukemia (CML). Lymphoma is further subdivided into non-Hodgkin lymphoma and Hodgkin lymphoma. Rare blood disorders include myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs).
The market has been segmented into significant geographies: North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The regional segment will provide a detailed analysis of major countries, including the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia, and India. For market estimates, data will be provided for 2024 as the base year, with forecasts for 2025 and a 2030 forecast value.
The report aims to:
- Analyze types of blood cancer therapeutics.
- Analyze global market size and segmentation.
- Understand market constraints and drivers.
- Provide detailed market forecasts for 2030.
- Assess market shares, competitiveness, and industry structure.
- Identify potential long-term impacts on the blood cancer therapeutics market.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2024 | ||||||||||||||||
| Forecast period considered | 2025-2030 | ||||||||||||||||
| Base year market size | $70.8 billion | ||||||||||||||||
| Market size forecast | $125.5 billion | ||||||||||||||||
| Growth rate | CAGR of 10.2% for the forecast period of 2025-2030 | ||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||
| Segments covered | By Cancer Type, Therapy Type, and Region | ||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, South America, Middle East and Africa | ||||||||||||||||
| Countries covered | U.S., Canada, Mexico, Germany, France, Italy, U.K., Spain, Austria, Denmark, the Netherlands, Poland, Sweden, Switzerland, China, Japan, India, South Korea, Australia, Malaysia, New Zealand, Singapore, Thailand, Vietnam, Brazil, Argentina, Colombia, Paraguay, Peru, Middle East, Africa | ||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||
| Companies studied |
|
||||||||||||||||
Frequently Asked Questions (FAQs)
- Rise in Blood Cancer Cases
- The Increasing Burden of Blood Cancers
- Increasing R&D Spending by Market Players
- Rise in Government Funding and Pharmaceutical R&D Spending
- Key challenges include- Rising Generic Competition and Patent Expiration; Availability of Affordable Chemotherapeutics Restricts Growth of Advanced Therapies; High Cost of Blood Cancer Therapeutics
- Key opportunities include- Potential of Blood Cancer Therapeutics; Emerging Markets; Technological Advances in Drug Manufacturing
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Related Reports
Cancer Profiling and Pathways: Technologies and Global Markets
The global market for cancer profiling and pathway technologies is expected to grow from $18.3 billion in 2025 and is projected to reach $33.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.2% during the forecast period of 2025 to 2030.
Biological Therapies for Cancer: Technologies and Global Markets
The global biological therapies market for cancer is expected to grow from $157 billion in 2025 and is projected to reach $225 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.5% during the forecast period of 2025 to 2030.
Brain Tumor Therapeutics: Global Markets to 2030
The report provides an analysis of brain tumor therapeutics and analyzes market trends. Using 2024 as the base year, the report provides estimated market data for 2025 through 2030. The market in this report is segmented by therapy type, patient age, end user, and region. The report covers regulatory scenarios, drivers, restraints, opportunities, and the market share for key companies.
Nanotechnology in Cancer Treatment: Technologies and Global Markets
The report provides an analysis of the global market for nanotechnology in cancer treatment. Using 2023 as the base year, the report provides estimated market data for 2024 through 2029. The market in this report is segmented into product type, cancer type, and region. The report concludes with profiles of the major players in the market.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Blood Cancer Therapeutics: Global Markets to 2030
The global market for blood cancer therapeutics was valued at $77.1 billion in 2025 and is projected to reach $125.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 10.2% from 2025 to 2030.
Clinical Nutrition: Global Markets to 2031
The global market for clinical nutrition is expected to grow from $79.5 billion in 2026 and is projected to reach $104.7 billion by the end of 2031, at a compound annual growth rate (CAGR) of 5.6% during the forecast period of 2026 to 2031.
Substance Use Disorder Treatment: Global Markets to 2030
The global substance use disorder (SUD) treatment market was valued at $11.6 billion in 2025, and it is expected to reach $14.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 4.6% from 2025 to 2030.
In Vitro Toxicity Testing: Technologies and Global Markets
The global in vitro toxicity testing market was valued at $17.4 billion in 2025 and is projected to reach $28 billion by the end of 2030, at a compound annual growth rate of 10% from 2025 to 2030.
Cardiovascular Drugs: Global Markets to 2030
The global market for cardiovascular drugs was valued at $183.7 billion in 2025 and is estimated to reach $228.6 billion by 2030, at a compound annual growth rate (CAGR) of 4.5% from 2025 through 2030.
Top Trending Reports
2025 Medical Devices Research Review
Get a concise view of the medical devices sector with BCC Research’s 2025 review covering market dynamics, emerging technologies and industry developments.
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies (SUTs) for biopharmaceuticals was valued at $8.3 billion in 2025 and, is estimated to reach $9.2 billion by 2026 and $16.3 billion by 2031, at a compound annual growth rate (CAGR) of 12.2% from 2026 through 2031.
Biologic Therapies for Wound Care: Technologies and Global Markets
The global market for wound care biologics is expected to grow from $7 billion in 2025 and is projected to reach $10.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 9.1% during the forecast period of 2025 to 2030.
Power Infrastructure for Data Centers: Global Markets
This report provides a comprehensive analysis of global power infrastructure for data centers market, segmented by power infrastructure component, data center type, and end-use. It includes global revenue for the base year of 2024 and estimated data for the forecast period 2025 through 2030. The report focuses on trends, challenges, and the competitive landscape, including market share of leading companies and company profiles with financials, product portfolios, and recent developments.
State of the Life Sciences Industry - 2026 Second Quarter Review
Discover BCC Research’s Q2 2026 life sciences industry review, highlighting market trends, innovation, sector performance, and growth opportunities.
Report Highlights
The global market for blood cancer therapeutics should grow from $38.5 billion in 2018 to $64.8 billion by 2023 at a compound annual growth rate (CAGR) of 11.0% from 2018 to 2023.
Report Includes
- 41 data tables and 48 additional tables
- An overview of the global blood cancer therapeutics markets within the industry
- Analyses of global market trends with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Regional dynamics of the market covering North America, Europe, Asia-Pacific and other emerging economies
- Discussion of major drivers, trends and challenges influencing blood cancer therapeutics market
- Information on the competitive environments, blockbuster drugs, pipeline analysis, patent analysis, and regulatory and reimbursement structure
- Coverage of regulatory environments for the United States, Europe and Japan; and information pertaining to the regulations for new drug launches
- A look at the reimbursement scenario outlined for the United States and Europe, and Pipeline analysis encompassing major disease area
- Examination of the competitive landscape and description of the major manufacturers involved in the blood cancer therapeutics market, key developments and product offerings
- Company profiles of leading market players, including AbbVie Inc., AstraZeneca plc, Bristol-Myers Squibb Co., GlaxoSmithKline plc, F. Hofmann-La Roche Ltd., and Novartis AG
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More